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Canavanine, diaminopropane, a-methylornithine and methylglyoxa1 bis(guanylhydrazone) decreased the in- 
tracellular polyamine concentrations in growing baby hamster kidney cells. Each of the inhibitors also pre- 
vented polyamine efflux into the extracellular medium. Concomitant with the decrease in pdyamine excre- 
tion was a change in the ~st~bution of polyamines in the extracellular medium. In each case there was 
a decrease in the amount of radioactivity present as free spermidine and an increase in that found as acetyl 
poIyamines. The magnitude of this shift correlated with the degree of inhibition of excretion. It may be 
that acetyl polyamines play a role in the regulation of polyamine excretion. 
Polyamine synthesis Polyamine xcretion 
I * INTRODUCTION 
There are three routes of catabolism foi 
poly~in~ in mammalian cells. The first is the 
direct oxidation of the polyamines to aldehydes via 
polyamine oxidase [l]. The second is the ‘so- 
called’ retroconversion pathway which converts 
spermine to spermidine and putrescine by a com- 
bination of acetylation and oxidation reactions 
[2,3]. The final route is elimination of polyamines 
from the cell either as free spermidine or as an 
acetylated derivative [4,5]. The last two pathways 
are related since each appears to be mediated via 
an acetyl intermediate [2,5]. 
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BHK-21/C13 cells, a non-transformed fibro- 
blast cell line, have very low levels of polyamine 
oxidase activity (Wallace and MacGowan, un- 
published), and consequently utilise the acetyla- 
tion/excretion pathway to regulate their in- 
tracellular polyamine concentrations [4,6]. A 
number of factors alter the excretion of poly- 
amines from BHK-21/C13 cells. For example, in- 
creasing the rate of cell growth completely stops 
polyamine excretion 141; transformation of the 
cells by an oncogenic virus, polyoma virus, has a 
similar effect f5]. Infection of the cells with herpes 
simplex virus type 1 also decreases the total 
amount of polyamine excreted 171. 
In this paper we have continued these studies by 
ex~ning the effects of four compounds on the 
excretion and acetylation of poly~ines in con- 
fluent cultures of BHK-21/C13 cells. Three of 
these compounds are known to be inhibitors of 
polyamine biosynthesis and the fourth is an 
analogue of arginine known to affect protein 
metabolism [8]. Some of this work has been 
published as a prelimina~ ~ommu~cation 191. 
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2. MATERIALS AND METHODS 
BHK-21/C13 cells were grown to confluence in 
Dulbecco’s medium supplemented with 10% (v/v) 
horse serum as described previously [5]. Cells for 
excretion experiments were labeled with 
[3H]putrescine (1 &X/ml) for 16-20 h and then 
transferred to medium containing no radioactivity. 
The medium was changed again at confluence and 
samples were taken at various times thereafter [4]. 
Polyamines were extracted from cells and 
medium in 0.2 M HC104 and were analysed by 
fluorescence or by liquid scintillation spectrometry 
after dansylation and separation of the dansyl 
derivatives by TLC [lo]. DNA, RNA and protein 
were extracted from BHK cells as described 
previously and analysis performed by standard 
assay procedures [5]. All drugs were dissolved in 
0.9% (w/v) NaCl and filter-sterilized before use. 
3. RESULTS 
All of the four compounds tested inhibited 
polyamine synthesis in BHK-21/C13 cells in 
culture (table 1). MGBG was the most effective 
drug depleting both spermidine and spermine by 45 
and 63070, respectively. Diaminopropane was also 
effective in decreasing the cellular content of both 
polyamines. Canavanine decreased the spermidine 
content but produced a small increase in the con- 
centration of spermine (table 1). cu-Methylorni- 
thine was the least effective drug as an inhibitor of 
polyamine biosynthesis. As was found with 
canavanine, the spermidine content was decreased 
Table 1 
The effect of polyamine inhibitors on the cellular content of DNA, RNA, protein and polyamines 
Inhibitor 
None 
cr-Methylornithine 
Diaminopropane 
Canavanine 
Methylglyoxal bis(guanylhydrazone) 
Con- Protein DNA RNA Put Spd Spm Total 
centration (mg) kg/mg (nmol/mg 
(mM) protein) protein) 
- 2.28 91.7 126.1 0.37 9.64 5.64 15.28 
5.00 2.48 66.9 120.8 nd 4.62 8.68 13.30 
1 so 2.03 98.3 142.1 nd 5.25 5.33 10.58 
1.00 1.84 71.6 120.2 0.02 3.94 6.03 9.97 
0.01 1.99 70.3 108.5 2.34 5.27 2.10 7.37 
Cells were grown and all parameters were measured as described in section 2. Values are average of duplicates. 
Putrescine (Put) could not be measured in cells treated with cY-methylornithine or diaminopropane due to interference 
of the drugs with the dansyl putrescine spot. nd, not determined; Spd, spermidine; Spm, spermine 
Table 2 
The effect of inhibitors of polyamine biosynthesis on the release of polyamines from BHK-21/C13 cells 
Inhibitor Concentration 
(mM) 
Total radioactivity 
in medium 
(cpm x 10m4/plate) 
% of control 
value 
None 2.72 f 0.08 100.0 
cu-Methylornithine 5.00 0.67 f 0.14 24.6 
Diaminopropane 1.50 2.04 f 0.05 75.0 
Canavanine 1.00 2.35 f 0.09 86.4 
Methylglyoxal bis(guanylhydrazone) 0.01 0.76 f 0.07 27.9 
Intracellular polyamines were labelled as described in section 2. Inhibitors were dissolved in 0.9% (w/v) 
NaCl and were added to the cultures 24 h before sampling. Medium, plus inhibitors, was replaced 12 h 
before harvesting. Values are mean f SD (n = 3) 
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Table 3 
Distribution of radioactivity in the extracellular medium of BHK-2UC13 cells in the presence of inhibitors 
Inhibitor Concentration 
(mM1 
Radioactivity (To of to&I) 
Acetyl Spermidine 
polyamines 
None - 64 26 
cu-Methylornithine 5.00 22 70 
Diaminopropane 1.50 52 41 
Canavanine 1.00 57 37 
Methylglyoxal bis(guanylhydrazone) 0.01 22 60 
Acid extracts of extracellular medium from the experiment described in the legend to table 2 were 
dansylated and the dansyl polyamines were separated by TLC [lo]. The radioactivity in each polyamine 
was determined by liquid scint~lation spectrometry. VaIues are average of dupIicates and are expressed 
as a percentage of the total radioactivity in the medium, since the medium contains different amounts of 
radioactivity (table 2). Spermine and putrescine were also present in the medium. These amines each 
accounted for less than 10% of the total radioactivity 
and the spermine content increased. The increase 
was more marked, in this case being about 54%. 
All of the inhibitors except a-methylornithine in- 
hibited cell growth (table 1). Diaminopropane had 
little effect on the DNA content of the cells, but cy- 
methylornithine, canavanine and MGBG all 
decreased the amount of DNA present by about 
25% suggesting that these drugs block cell growth 
prior to S phase. None of the drugs had a signifi- 
cant effect on the RNA content of the cells. 
All of the drugs decreased the excretion of 
polyamines from confluent cell cultures (table 2). 
a-Methylornithine and MGBG were most effective 
producing about a 75% decrease in the amount of 
radioactivity found in the extracellular medium. 
The other compounds produced much smaller 
decreases of the order of 14-25%. 
Analysis of the dist~bution of radioactivity in 
the medium revealed that spermidine and 
acetyl~ly~~es accounted for more than 80% of 
the total radioactivity, with spermidine being the 
major product (table 3). The presence of the drugs 
altered the distribution of the radioactivity be- 
tween these polyamines. In each case, the amount 
of radioactivity in spermidine decreased while that 
in the acetylpolyamine fraction increased. The 
most marked changes were seen in cells treated 
with cw-methylornithine and MGBG, the two drugs 
which most affected polyamine excretion (tables 
2,3). Hydrolysis of the medium [ 161 released most- 
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ly free spermidine and some free spermine (not 
shown). 
4. DISCUSSION 
In every case, depletion of intracellular 
polyamine concentrations resulted in a decrease in 
the total excretion of polyamines (tables 1,2). This 
suggests that there is a mechanism for the conser- 
vation of existing polyamines. A similar observa- 
tion was seen in BHK cells induced to grow by the 
addition of fresh serum [4]. In this case, 
polyamines were required for cell growth and 
therefore excretion was stopped. At the same time, 
the uptake of polyamines by these cells was in- 
creased [4] indicating a complete switch from the 
catabolic to anabolic mode of metabolism. It may 
be that uptake and excretion of polyamines are 
linked in an inverse manner such that when uptake 
is low, excretion is high and vice versa. Indeed, 
BHK cells treated with ~-methylornithine [15] or 
with canavanine (H.M. Wallace, unpublished) 
showed enhanced uptake of exogenous poly- 
amines. 
The degree of inhibition of polyamine biosyn- 
thesis was not related to the amount of inhibition 
of excretion. Neither did the mechanism of inhibi- 
tion correlate with excretion. a+Methylornithine 
and diaminopropane are recognised inhibitors of 
ODC, the first enzyme in the polyamine biosyn- 
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thetic pathway. How canavanine influences 
polyamine metabolism is not known but the results 
in table 1 indicate that it is an inhibitor of ODC, 
having similar effects to a-methylornithine. (Y- 
Methylornithine and diaminopropane act by two 
completely separate mechanisms. The former inac- 
tivates the enzyme by binding to the active site 
[ 111, while the latter inhibits ODC via the produc- 
tion of an antizyme [12]. MGBG inhibits biosyn- 
thesis at yet another site, S-adenosylmethionine 
decarboxylase [ 141, an effect which produces a dif- 
ferent pattern of decreased polyamine concentra- 
tions (table 1). MGBG had a similar effect on ex- 
cretion of polyamines from serum-deprived cells 
1131. 
Whenever total polyamine excretion was 
decreased there was an alteration in the distribu- 
tion of radioactivity in the extracellular medium 
(table 3), and a shift in radioactivity from sper- 
midine to acetyl polyamines. The magnitude of 
this shift correlated with the degree of inhibition of 
excretion (tables 2,3). a-Methylornithine and 
MGBG, the most effective inhibitors of excretion, 
produced the greatest increase in the proportion of 
acetylpolyamines. The results suggest hat the in- 
hibitors directly affect polyamine acetylation 
either by increasing the activity of polyamine 
acetyltransferase or by decreasing the activity of 
polyamine deacetylase. In BHK-21/C13 cells, the 
former seems to be the case, since MGBG has been 
found to increase the acetylase activity by 4-5-fold 
(H.M. Wallace, unpublished). 
The highest concentrations of acetylpolyamines 
were found in the medium where excretion was 
most decreased; it may be therefore that the in- 
crease in the amount of acetylpolyamines in the ex- 
tracellular medium, either directly or indirectly, 
regulates polyamine excretion (tables 2,3). 
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